Mankind Pharma has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company vide circular resolution passed today June 10, 2025, has allotted 57,709 equity shares of face value of Re. 1/- each of the Company to the eligible employees who have exercised their options pursuant to the ESOP Plan. These shares shall rank with the existing equity shares of the Company. Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased from 41,26,71,039 Equity Shares to 41,27,28,748 Equity Shares having face value of Re. 1/- each. In terms of Regulation 10(c) of the SEBI ESOP Regulations, the details are enclosed as ‘Annexure – I’. The same is being uploaded on website of the Company at www.mankindpharma.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1783.55 |
| Dr. Reddys Lab | 1277.80 |
| Cipla | 1400.70 |
| Zydus Lifesciences | 1088.90 |
| Lupin | 2268.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: